Zhejiang Ausun Pharmaceutical Co., Ltd. (SHA:603229)
China
· Delayed Price · Currency is CNY 9.49
+0.18 (1.93%)
Mar 10, 2026, 11:29 AM CST
SHA:603229 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Net Income | 184.84 | 206.79 | 253.9 | 235.38 | 145.93 | 86.84 | Upgrade
|
| Depreciation & Amortization | 63.52 | 63.52 | 40.59 | 34.48 | 30.02 | 25.43 | Upgrade
|
| Other Amortization | 0.14 | 0.14 | - | - | - | - | Upgrade
|
| Loss (Gain) From Sale of Assets | - | - | - | 1.58 | 0.52 | 0.52 | Upgrade
|
| Asset Writedown & Restructuring Costs | 9.56 | 9.56 | 5.62 | 4.95 | 5.24 | 3.7 | Upgrade
|
| Loss (Gain) From Sale of Investments | -28.05 | -28.05 | -0.4 | -5.4 | -7.9 | -0.04 | Upgrade
|
| Provision & Write-off of Bad Debts | 7.26 | 7.26 | 0.34 | - | - | - | Upgrade
|
| Other Operating Activities | 81.75 | -3.95 | -3.68 | -35.46 | 7.37 | 27.79 | Upgrade
|
| Change in Accounts Receivable | -23.03 | -23.03 | 34.45 | -69.41 | -101.89 | 24.44 | Upgrade
|
| Change in Inventory | -45.59 | -45.59 | -79.38 | -153.14 | -56.99 | -6.51 | Upgrade
|
| Change in Accounts Payable | -6.19 | -6.19 | -26.04 | 97.47 | 151.35 | -22.37 | Upgrade
|
| Operating Cash Flow | 241.67 | 177.93 | 221.85 | 120.57 | 173.9 | 138.47 | Upgrade
|
| Operating Cash Flow Growth | -18.21% | -19.80% | 84.00% | -30.67% | 25.59% | 57.84% | Upgrade
|
| Capital Expenditures | -97.87 | -111.3 | -163.47 | -271.91 | -310.85 | -92.95 | Upgrade
|
| Sale of Property, Plant & Equipment | 0.32 | 0.04 | 0.19 | 0.19 | 0.21 | 0.01 | Upgrade
|
| Investment in Securities | -4.01 | -2.25 | -18 | 95.69 | -114.72 | -12.72 | Upgrade
|
| Other Investing Activities | 19.4 | -6.46 | 5.81 | -1.81 | -6.94 | 0.22 | Upgrade
|
| Investing Cash Flow | -82.16 | -119.97 | -175.47 | -177.85 | -432.3 | -105.44 | Upgrade
|
| Short-Term Debt Issued | - | 270.1 | 330 | - | - | - | Upgrade
|
| Long-Term Debt Issued | - | - | - | 235.05 | 219.8 | 81 | Upgrade
|
| Total Debt Issued | 375.18 | 270.1 | 330 | 235.05 | 219.8 | 81 | Upgrade
|
| Short-Term Debt Repaid | - | -300 | -271.7 | - | - | - | Upgrade
|
| Long-Term Debt Repaid | - | -0.94 | -0.63 | -103.15 | -151 | -84.9 | Upgrade
|
| Total Debt Repaid | -301.24 | -300.94 | -272.33 | -103.15 | -151 | -84.9 | Upgrade
|
| Net Debt Issued (Repaid) | 73.94 | -30.84 | 57.67 | 131.9 | 68.8 | -3.9 | Upgrade
|
| Issuance of Common Stock | - | - | 473.93 | - | - | 413.4 | Upgrade
|
| Common Dividends Paid | -90.36 | -84.22 | -57.45 | -37.67 | -19.97 | -13.4 | Upgrade
|
| Other Financing Activities | -69.76 | 6.84 | -4.23 | 0.69 | -11.8 | -5.9 | Upgrade
|
| Financing Cash Flow | -86.17 | -108.22 | 469.93 | 94.92 | 37.03 | 390.2 | Upgrade
|
| Foreign Exchange Rate Adjustments | 13.82 | 10.84 | 7.95 | 37.18 | -10.63 | -19.92 | Upgrade
|
| Net Cash Flow | 87.15 | -39.42 | 524.25 | 74.82 | -232 | 403.3 | Upgrade
|
| Free Cash Flow | 143.8 | 66.62 | 58.38 | -151.35 | -136.95 | 45.52 | Upgrade
|
| Free Cash Flow Growth | 6.45% | 14.12% | - | - | - | 19.45% | Upgrade
|
| Free Cash Flow Margin | 19.14% | 8.38% | 7.15% | -19.80% | -24.04% | 11.12% | Upgrade
|
| Free Cash Flow Per Share | 0.17 | 0.08 | 0.07 | -0.19 | -0.17 | 0.06 | Upgrade
|
| Cash Income Tax Paid | 9.82 | 13.09 | -1.39 | 6.35 | 16.06 | 2.78 | Upgrade
|
| Levered Free Cash Flow | 16.63 | -63.23 | -108.01 | -179.91 | -29.41 | 34.02 | Upgrade
|
| Unlevered Free Cash Flow | 21.47 | -58.38 | -103.01 | -176.09 | -28.49 | 34.89 | Upgrade
|
| Change in Working Capital | -77.34 | -77.34 | -74.54 | -114.96 | -7.29 | -5.76 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.